InvestorsHub Logo
Followers 1
Posts 54
Boards Moderated 0
Alias Born 03/02/2014

Re: BioInfo post# 5198

Tuesday, 03/04/2014 1:42:03 PM

Tuesday, March 04, 2014 1:42:03 PM

Post# of 718338
The timing on the number of events dose not concern me much. Nor dose the apparent reluctance of NWBO to release trial enrollment numbers. GMB is a very rare form of cancer to begin with. There will be a small pool of patients to start with and I expect only a fraction of those to be willing to participate in an experimental treatment. If it were me, I'd have to think long and hard about it. I don't expect the enrollment to be quick or easy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News